U 86170

Drug Profile

U 86170

Alternative Names: U 77566; U 86174

Latest Information Update: 22 Jun 2001

Price : $50

At a glance

  • Originator Pharmacia Corporation
  • Class Antiparkinsonians; Neuroprotectants
  • Mechanism of Action Dopamine D2 receptor agonists; Serotonin 1A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Parkinson's disease; Psychotic disorders

Most Recent Events

  • 22 Jun 2001 No-Development-Reported for Parkinson's disease in USA (Unknown route)
  • 22 Jun 2001 No-Development-Reported for Psychotic disorders in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top